ORTHOCELL LIMITED — Director's Dealing 2016

Mar 3, 2016

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name	of entity	Orthocell Limited
ABN	57 118	897 135

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Qi Xiao Zhou
Date of last notice	25/11/2014

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.
Date of change	26/02/2016
No. of securities held prior to changeQi Xiao Zhou	5,955,673 Ordinary Shares150,000 Unlisted Options exercisable at$0.62 on or before 24 November 2017
Class	Ordinary SharesUnlisted Warrants
Number acquired	40,568 Ordinary Shares54,767 Unlisted Warrants
Number disposed	-
Value/ConsiderationNote: If consideration is non-cash, provide details and estimated valuation	Nil

• See chapter 19 for defined terms.

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change
Qi Xiao Zhou	5,996,241 Ordinary Shares
	150,000 Unlisted Options exercisable at
	$0.62 on or before 24 November 2017
	54,767 Unlisted Warrants exercisable at
	$0.58 on or before 19 November 2020
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back	Issue of securities as approved byshareholders at a General Meeting on 27
	January 2016

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contractN/ANature of interestN/AName of registered holder(if issued securities)N/ADate of changeN/ANo. and class of securities towhich interest related prior tochangeNote: Details are only required for a contract in relationto which the interest has changedN/AInterest acquiredN/AInterest disposedN/AValue/ConsiderationNote: If consideration is non-cash, provide details and anestimated valuationN/A

Detail of contractN/ANature of interestN/AName of registered holder(if issued securities)N/ADate of changeN/ANo. and class of securities towhich interest related prior tochangeNote: Details are only required for a contract in relationto which the interest has changedN/AInterest acquiredN/AInterest disposedN/AValue/ConsiderationNote: If consideration is non-cash, provide details and anestimated valuationN/A

Interest after change

N/A

Part 3 Closed Period

Were the interests in the securities or No contracts detailed above traded during a +closed period where prior written clearance was required?

• See chapter 19 for defined terms.

Appendix 3Y Page 2

Appendix 3Y Change of Director’s Interest Notice

If so, was prior written clearance	N/A
provided to allow the trade to proceed
during this period?
If prior written clearance was provided,	N/A
on what date was this provided?

• See chapter 19 for defined terms.

Appendix 3Y Page 3